{"id":"visipaque-hydrocortancyl","safety":{"commonSideEffects":[{"rate":null,"effect":"Contrast-induced nephropathy"},{"rate":null,"effect":"Allergic reactions (mild to severe)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Flushing and warmth sensation"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL1200507","moleculeType":"Unknown","molecularWeight":"1550.19"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Visipaque contains iopamidol, an iodinated contrast agent that increases radiodensity in targeted anatomical regions, allowing for improved visualization during angiography and other radiographic procedures. The iso-osmolar formulation is designed to minimize osmotic stress on tissues and reduce nephrotoxicity compared to hyperosmolar contrast agents.","oneSentence":"Visipaque is a non-ionic, iso-osmolar contrast medium that enhances radiographic visualization of blood vessels and organs during diagnostic imaging procedures.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:15:22.450Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Coronary angiography and ventriculography"},{"name":"Peripheral vascular angiography"},{"name":"Cerebral angiography"},{"name":"Urography and other radiographic imaging procedures"}]},"trialDetails":[{"nctId":"NCT00804531","phase":"PHASE4","title":"Intra-discal Steroid Injection for MODIC I Discopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-04","conditions":"Back Pain Lower Back Chronic","enrollment":137}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Visipaque - Hydrocortancyl","genericName":"Visipaque - Hydrocortancyl","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Visipaque is a non-ionic, iso-osmolar contrast medium that enhances radiographic visualization of blood vessels and organs during diagnostic imaging procedures. Used for Coronary angiography and ventriculography, Peripheral vascular angiography, Cerebral angiography.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}